Cracking the Code: Nucleic Acid Medicines Coming of Age
Published in Bioengineering & Biotechnology, Genetics & Genomics, and Biomedical Research

Organized by Alnylam, Ionis, HSCI, Nature, Nature Biotechnology and Nature Reviews Drug Discovery.
The 2025 conference brings together leading academics and industry professionals to explore developments and challenges in the rapidly evolving field of nucleic acid medicines. By uniting researchers from basic science, translational medicine, promising start-ups and biotechnology companies, the event aims to create a unique environment for meaningful dialogue and collaboration.
The conference will feature in-depth discussions on:
- Translational developments of basic nucleic acid biology
- Recent clinical successes using nucleic acid gene therapies
- Advancements in nucleic acid chemistry
The three-day program offers comprehensive coverage of applications of fundamental biology, a panel discussion and ample space to connect with editors, speakers and fellow attendees.
Follow the Topic
-
Nature
A weekly international journal publishing the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions.
-
Nature Biotechnology
A monthly journal covering the science and business of biotechnology, with new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences.
-
Nature Reviews Drug Discovery
A monthly journal aimed at everyone working in the drug discovery and development arena, publishing high-quality reviews and perspectives covering the entire field.
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in